METLIFE INC (MET)
US59156R1086 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to MET. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 79.48. This target is 24.02% above the current price.
MET was analyzed by 21 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about MET.
In the previous month the buy percentage consensus was at a similar level.
MET was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023-11-17 | Barclays | Reiterate | Overweight |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-14 | Jefferies | Upgrade | Hold -> Buy |
| 2023-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-08-14 | Argus Research | Maintains | Buy -> Buy |
| 2023-08-09 | Citigroup | Maintains | Buy -> Buy |
| 2023-08-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-03 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-07-17 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-06-15 | Citigroup | Maintains | Buy -> Buy |
| 2023-06-09 | Keefe, Bruyette & Woods | Reiterate | Outperform |
| 2023-06-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-26 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-05-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-05-05 | RBC Capital | Maintains | Outperform |
| 2023-04-20 | RBC Capital | Maintains | Outperform |
| 2023-04-12 | Barclays | Maintains | Overweight |
| 2023-04-12 | Morgan Stanley | Maintains | Overweight |
| 2023-04-05 | Wells Fargo | Maintains | Overweight |
| 2023-04-05 | Goldman Sachs | Maintains | Neutral |
| 2023-04-05 | Piper Sandler | Maintains | Overweight |
| 2023-02-02 | Morgan Stanley | Maintains | Overweight |
| 2023-01-18 | Wells Fargo | Maintains | Overweight |
| 2023-01-10 | Morgan Stanley | Maintains | Overweight |
| 2023-01-09 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-01-06 | JP Morgan | Maintains | Overweight |
| 2022-12-09 | Jefferies | Downgrade | Buy -> Hold |